Business Context and Reporting Period
Company: Universal Health Services, Inc. (UHS)
Filing Type: Form 8-K (Current Report)
Date of Report: September 26, 2024
Event: Entry into a Material Definitive Agreement involving the issuance of senior secured notes and the amendment of the senior secured credit facility.
Key Financial Metrics and Capital Structure
This filing details a significant refinancing transaction rather than operational performance metrics. Key financial figures include:
- New Debt Issuance:
- $500 million aggregate principal of 4.625% Senior Secured Notes due 2029.
- $500 million aggregate principal of 5.050% Senior Secured Notes due 2034.
- Credit Facility Restructuring:
- New Revolving Credit Facility: Up to $1.3 billion (5-year term).
- New Tranche A Term Loan Facility: Up to $1.2 billion (maturing September 26, 2029).
- Debt Repayment: Proceeds were used to repay $2,199 million of the outstanding Tranche A term loan facility under the existing credit agreement.
- Interest Rates (Credit Facility): Initial margins are 0.375% for ABR Loans and 1.375% for Term Benchmark/RFR Loans, based on the Consolidated Net Leverage Ratio.
- Credit Ratings: The new Notes received investment-grade ratings from both Moody's and S&P upon issuance.
Material Changes Versus Prior Period
The primary material change is the replacement of the existing senior secured credit facilities with a new structure and the issuance of new long-term debt.
- Debt Maturity Profile: The company extended its debt maturity profile by issuing notes due in 2029 and 2034, replacing a portion of the existing term loan maturing sooner.
- Facility Capacity: The new credit agreement provides a combined capacity of $2.5 billion ($1.3 billion revolving + $1.2 billion term loan), replacing the previous facility structure.
- Collateral Structure: The new Notes and credit facility are secured by first-priority liens on the Issuer's and Subsidiary Guarantors' assets, ranking equally with existing secured notes (2026, 2030, and 2032).
Guidance, Outlook, and Material Terms
The filing does not contain operational guidance or management commentary on future earnings. However, it outlines critical terms affecting future financial obligations:
- Optional Redemption: The Issuer may redeem the 2029 Notes prior to September 15, 2029, and the 2034 Notes prior to July 15, 2034, at 100% of principal plus accrued interest and a "make whole" premium. After these dates, redemption is at 100% of principal plus accrued interest.
- Change of Control: If a change of control occurs and the Notes lose their investment-grade rating, holders have the right to require repurchase at 101% of principal plus accrued interest. This covenant is initially suspended due to the current investment-grade ratings.
- Covenants: The Indentures limit the Issuer's ability to consolidate, merge, sell substantially all assets, create mortgages on principal properties, or engage in certain sale and lease-back transactions.
- Repayment Schedule: The new Tranche A term loan requires quarterly repayments of 2.5% of the original principal for the first eight quarters, increasing to 5% thereafter, with the balance due at maturity.
Investor Verification Checklist
- Verify the specific "make whole" premium calculation methodology for early redemption of the 2029 and 2034 Notes.
- Confirm the current Consolidated Net Leverage Ratio to determine if interest margins on the new credit facility will remain at the initial 0.375%/1.375% levels.
- Review the full text of the Tenth Amendment to the Credit Agreement (Exhibit 10.1) for detailed covenants and definitions of permitted liens.
- Monitor the status of the collateral release conditions, specifically whether the liens on the collateral securing the Notes will be released if the Notes maintain investment-grade ratings and other first lien obligations are released.
- Assess the impact of the new debt service obligations (interest and principal amortization) on future cash flow projections.